PACIRA BIOSCIENCES, INC. (PCRX) Operating cash flow 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$152.0MFY2025 · since FY2016: $33.5M → $152.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $152.0M | -19.7% |
| FY2024 | $189.4M | +22.5% |
| FY2023 | $154.6M | +6.5% |
| FY2022 | $145.3M | +15.6% |
| FY2021 | $125.7M | +63.2% |
| FY2020 | $77.0M | +9.2% |
| FY2019 | $70.5M | +44.3% |
| FY2018 | $48.9M | +174.8% |
| FY2017 | $17.8M | -46.8% |
| FY2016 | $33.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice